Regenerative Medicine Foundation


Our mission is to accelerate regenerative medicine to improve health and deliver cures
previous arrow
next arrow
Regenerative Medicine

Regenerative Medicine

A new paradigm of medicine that relies on stem cells capacity to regenerate, regrow, and fully heal damaged tissues and organs in our bodies.
Ethics and Policy

Ethical Advancement

We are committed to the ethical advancement of an innovative medicine powered by regenerative, restorative, and curative technologies.
Improving Health

Improve Health

All we do is in service of health, life, and the alleviation of human suffering.
Deliver Cures

Deliver Cures

Alleviating the suffering and restoring the hope of patients, and of their loved ones, is what fuels our passion and our work.

Latest News, Opinions and Video

The Treatment That Could Crush Covid

The Treatment That Could Crush Covid

Early trials show signaling cells eliminate the virus, calm the immune response and repair tissue damage. By Kevin Kimberlin - Wall Street Journal...

Alzheimers Research Findings – Tufts University’s Dana Cairns and David Kaplan Speak with Bernie Siegel

Bernie's Interview with Dana Cairns & David Kaplan of Tufts University 0:00 Intro 1:30 Alzheimers Research Findings Review - Dana Cairns 4:01 Using...

Adult stem cells/glaucoma drug combo promotes diabetic wound healing in mice

Durham, NC – A new study released today in STEM CELLS Translational Medicine shows promise of a major breakthrough in healing chronic foot ulcers...

RMF’s Bernie Siegel talks with Michael May of CCRM about the future of stem cell development

Michael May, CEO of Centre for Commercialization of Regenerative Medicine (Canada)

New platform enables long-term tracking of stem cell-derived tissues after transplantation

Durham, NC – A new platform reported on today in STEM CELLS Translational Medicine (SCTM) will enable long-term tracking of cardiomyocytes produced...
Sanford Burnham Prebys receives CIRM award for COVID-19 research

Sanford Burnham Prebys receives CIRM award for COVID-19 research

Researchers will use 'mini lungs in a dish' to test promising drug candidates Sanford Burnham Prebys Medical Discovery Institute has received an...

Alliance for Regenerative Rehabilitation and Training Receives $5 Million NIH Grant to Continue Innovative Work

PITTSBURGH – The National Institutes of Health (NIH) has renewed a five-year grant for $5 million for the Alliance for Regenerative Rehabilitation...

Akron Biotech Submits eCTD Drug Master Files with FDA for Its Suite of cGMP Immunotherapy Cytokines

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotechnology, which develops and manufactures cGMP-compliant cytokines and other ancillary materials to...
University of Miami Miller School-led technology paves way for islet regeneration in human pancreas

University of Miami Miller School-led technology paves way for islet regeneration in human pancreas

Study published in Nature Communications By University of Miami Health System, Miller School of Medicine  - Contact patient services Miami, FL -...

Adipose-derived stem cells significantly improve fat graft retention in breast augmentation

Durham, NC – Results of a clinical trial released today in STEM CELLS Translational Medicine indicates that breast augmentation in patients treated...

Working with Policy Leaders in the United States

Making safe and effective treatments available for patients

Regenerative cellular therapies represent the next generation of groundbreaking treatments that are showing great promise in cardiology, neurology, oncology, orthopedics, ophthalmology, and other areas. Several well-designed clinical trials are being conducted under FDA investigational new drug (IND) protocols. At the same time, a handful of clinics have caused patient harm or made questionable claims, taking advantage of vulnerable patients and casting a negative light on this emerging science and industry.
Marks-Patterson-Siegel-and-Marchibroda Washington DC Policy Meeting
Regenerative Medicine Foundation Logo

What We Do


We Produce the World Stem Cell Summit, the RegMed Capital Conference, the Stem Cell Action Awards, and other events.

Patient Advocacy

We inform, celebrate and mobilize the global advocacy movement consisting of patients, advocates and medical philanthropies, all supporting regenerative medicine, including stem cell research and cell therapies.


Since 2003 we have a track record fostering a supportive regulatory and societal framework for regenerative medicine.


We educate the scientific community, public and media through our official, peer-reviewed, journal partner STEM CELLS Translational Medicine, the Regenerative Medicine Weekly Newsletter, social media channels, speaking engagements and media interviews.

A Trusted Network

Regenerative Medicine Foundation unites the world’s leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies, and patient organizations.
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.

Join Our Mailing List

Pin It on Pinterest